Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Rising Pharmaceuticals launches Pregabalin Capsules in US market

Posted On: 2019-07-22 11:59:02

Laurus Labs Ltd. (BSE: 540222, NSE: Lauruslabs, ISIN: INE947Q01010), a leading research and development driven pharmaceutical company along with its exclusive distribution partner Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company, announce the launch of the generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, & 300 mg) in US market. Rising recently received the final approval from the U.S. Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA).

Pregabalin Capsules are indicated for management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, for adjunctive therapy for the treatment of partial onset seizures in patients 4 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury. The product should be taken only as prescribed. Pregabalin Capsules and had U.S. sales of approximately $5,497 million for the 12 months ending March 2019, according to IMS Health.

"Laurus Labs is a fully integrated pharmaceutical company, backed by the state of the art manufacturing facilities in Visakhapatnam, Andhra Pradesh. We are happy to develop and manufacture the Pregabalin capsules for our exclusive distribution partner Rising Pharmaceuticals in US. Currently we have 5 billion units per year capacity which can be expanded to 8 million units per year based on the demand. As we move forward in the FDF segment backed by our strong API manufacturing facilities, with strategic partnerships in place, we will strengthen our portfolio for driving long-term, sustainable growth by leveraging our partnerships and global presence," said Dr. Satyanarayana Chava, Founder & CEO, Laurus Labs.

"The commercialization of Pregabalin Capsules is one of the largest volume launches for the company this year and will provide a cost effective treatment option for people living with debilitating neuropathic pain conditions," said Vimal Kavuru, Chief Executive Officer for Rising Pharmaceuticals.

Rising Pharmaceuticals sells generic prescription products and over-the-counter pharmaceutical products under the Rising label to leading wholesalers, chain drug stores, distributors and mass merchandisers.

Shares of Laurus Labs Ltd was last trading in BSE at Rs.350.4 as compared to the previous close of Rs. 350.05. The total number of shares traded during the day was 359 in over 25 trades.

The stock hit an intraday high of Rs. 351.05 and intraday low of 350. The net turnover during the day was Rs. 125705.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Shaily Engineering Plastics Limited clarifies on media reports regarding GST Search

Welspun Corp Ltd bags contracts for supply of 179 KMT pipes

Maharashtra Seamless secures Prestigious ONGC Orders

NBCC India Ltd receives order from Deparment of Revenue

GST search in Shaily Engineering Plastics Ltd's Rania Unit

Ecoplast Ltd to shut down Guwahati plant of subsidiary

KNR Constructions Ltd receives work order of Rs. 165.67 crores

Urja Global Ltd enters into JV for Electric Car

Banco Products India Ltd approves disinvestment

Bank of India board approves fund raising through issue of upto 125 crore shares

Ind-Ra affirms JK Paper's long-term issuer rating

Security and Intelligence Services India Ltd to acquire 51% in Adis Enterprises Pvt Ltd

ITC Ltd acquires stake in Delectable Technologies Pvt. Ltd.

Dynacons recognized as part of the Deloitte Technology Fast 50 India 2019

TCS' Advanced Drug Development Suite wins the India Pharma Award 2019

Zensar Partners with Education Africa to support students of Business Management

Fire at Oriental Aromatics Ltd's catalyst plant

Mitsu Chem Plast Ltd Board to consider Bonus Issue

Shri Jairam Sridharan, CFO of AXIS Bank resigns

Carnation Industries Ltd shuts plant for maintenance, repays dues to SBI, PNB

Issue of US$ 500 Million 3.50 Per Cent Notes By REC Limited

Vascon Engineers Ltd receives Rs. 132.69 crores work order from AAI

KEC International wins New Orders of Rs. 1,025 crore

RBI imposes penalty of Rs. 25 lakh on Andhra Bank

JSW Steel Ltd to seek clarifications on NCLAT order

G Bank, Myanmar Selects Infosys Finacle to Power its Growth

Thomas Cook India's Regional Maharashtra Tours witness a surge in demand of 27% from the State

Maruti Suzuki to proactively recall 63,493 Petrol Smart Hybrid variants of Ciaz, Ertiga and XL6 models

Dr. Reddy's Laboratories announces the launch of D.eferasirox Tablets for Oral Suspension, in the U.S. Market

Granules India Ltd clarifies on presence of NDMA in Metformin manufactured by the company

Bajaj Finance participates in QIP of RBL Bank Ltd

Cadila Healthcare Ltd receives EIR for API facility at Dabhasa, Gujarat

RBL Bank successfully closes QIP, raises Rs. 2,025 Crore

CARE revises ratings of Shakti Pumps India Ltd

Aite Group Names Majesco the Top 'Best-inClass' Vendor in the P&C Policy Administration Aite Matrix Report

Liberty Mutual Enhances Commercial Insurance Underwriting through Mastery of Big Data, adding more value to Brokers and Buyers

Shortlisted ideas from the European Tour Innovation Hub with Tata Communications show how latest digital technologies could revolutionise golf

Mercator Ltd board approves sale of PI in oil block

Pennar Industries bags orders worth INR 302 Crore

ICRA assigns credit ratings to NELCAST Ltd

Affle launches Vizury Engage360 to simplify omnichannel marketing

CARE A+ rating of Equitas Small Finance Bank Ltd reaffirmed

Reliance Power Ltd updates on rating action by Ind-RA

Moody's downgrades Yes Bank's ratings, assigns negative outlook

CARE reaffirms rating of NACL Industries Limited

Narayana Hrudayalaya announces discontinuation of Hospital Project in Kenya

Renascent Power acquires 75.01% stake in Prayagraj Power Generation Company Ltd

Sadbhav Tumkur Highway Private Ltd signs termination of concession agreement with NHAI

Nirlon Ltd, J.P. Morgan Sign Real Estate Transaction in Mumbai

Gati launches itself into the next phase of growth with All Cargo Logistics & Kintetsu World Express, Japan







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019